C4XD Results Video Video with CEO Clive Dix discussing recent results:
TV Interview A new one here - overview of the business. Good overview of their tech at 01:35:
TV Interview Morning, short TV interview with C4X CEO Clive Dix:
Recent developments The news on 29/3 was, no doubt, extraordinarily good for C4X and propelled the sp forward. Unfortunately it only went just a little higher than it was last year before falling back to the 80/90 range. Strange last trade today at 85 despite trading in the lower 90s all day.I sold out a long time ago at a small loss, missing the drop to the 50s, thank goodness. Im thinking about getting back in again but need the volatility to settle down before I do.Weak buy at present, based solely on the 29/3 news.Luck all.TP
Re: Trading update Agreed. The excitement generated by the new CEO with a good track record seems to have died out now. The programmes also don't appear to have moved on much. They've been talking about the orexin 1 antagonist for several years now - there was even once mention of a clinical trial application for q4 2016 but clearly that hasn't happened. I'm guessing they've run into a few problems, are burning cash and will be back to the markets for more funds soon.
Trading update Says absolutely nothing which can be used to evaluate progress since last statement. Let's have a few firm contracts, guys. Sp is reflecting market view of progress, and it's not impressed.TP
Results So, the fee for service revenue stream is terminated in favour of potential licencing deals.Obscure source of revenue is th downside here. Recent placing at 102 has failed to contain a falling sp which now stands at 92p.Recent aquisition may produce revenue though this is not clear.The innovative university spin out is on my watch list but I will need more evidence of revenue before I dip my toe in. Until then the sp is going only one way.TP